Pharmaceutical

SBTi approves Piramal Pharma’s GHG reduction targets

The SBTi has validated and approved India's Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets.

Sep 18, 2024 - 04:00
SBTi approves Piramal Pharma’s GHG reduction targets
The SBTi has validated and approved India's Piramal Pharma’s near-term greenhouse gas (GHG) emission reduction targets.
Read the original article

Tags:

Previous Article

Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants

Next Article

Long-Term Immunotherapy Benefits For Melanoma Shown in Ten-Year Survival Data

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Millions of people take birth control to treat endometriosis — but it doesn’t work

Opinion: Millions of people take birth control to treat...

Apr 5, 2023

After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes

After ‘SNL’ skit on sickle cell CRISPR therapy, advocat...

Dec 21, 2023

Back to school for biotech, Biogen’s potential pivot, & Illumina’s next chapter

Back to school for biotech, Biogen’s potential pivot, &...

Sep 8, 2023